Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

 

 

Current Weekly

More

Surveillance Summaries


Recommendations and Reports

  • Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017

    April 21, 2017
    Nonpharmaceutical interventions are strategies for disease, injury, and exposure control. They include actions that persons and communities can take to help slow the spread of respiratory viruses (e.g., seasonal and pandemic influenza viruses). These 2017 guidelines provide evidence-based recommendations on the use of NPIs in mitigating the effects of pandemic influenza. These guidelines update and expand the 2007 strategy.


Notifiable Diseases

  • Summary of Notifiable Infectious Diseases and Conditions — United States, 2014

    October 14, 2016
    Health-care providers in the United States are required to report certain infectious diseases to a specified state or local authority. A disease is designated as notifiable if timely information about individual cases is considered necessary for prevention and control of the disease. Each year, CDC publishes a summary of the cases of notifiable disease reported for the most recent year for which data is available. This report presents a summary of notifiable diseases for 2014.

  • Summary of Notifiable Noninfectious Conditions and Disease Outbreaks

    October 14, 2016
    The 2016 Summary of Notifiable Noninfectious Conditions and Disease Outbreaks — United States contains official statistics for the occurrence of nationally notifiable noninfectious conditions and disease outbreaks and is published for the second time in the same volume of MMWR as the annual Summary of Notifiable Infectious Diseases and Conditions. The summary includes seven chapters addressing the following subjects: acute pesticide-related illness and injury arising from occupational exposure, acute nonoccupational pesticide-related illness and injury, cancer, elevated blood lead levels among children, elevated blood lead levels among adults, silicosis, and foodborne and waterborne disease outbreaks. CDC’s Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) coordinated the development and publication of this annual summary.


Supplements



TOP